MLCCO
For therapeutic advances in human and veterinary oncology to occur novel findings related to the basic cellular mechanisms involved in the initiation and progression of cancer need to be translated from the bench to the bedside through the development of therapeutically relevant hypotheses that can be tested in a clinically relevant setting. The genome sequence of the dog is closely related to that of man and serves to emphasize the potential benefit of studying dogs with spontaneously occurring cancer in identifying disease genes and evaluating response to novel therapies that will advance both human and veterinary cancer therapy. Researchers at PennVet are actively translating basic scientific discoveries in the field of cancer biology and immunology into therapies that are being evaluated in on-going clinical trials.
More >>